Managing Myeloma
- 2011-05-13 - Oncolytics Biotech® Inc. Announces Phase I Multiple Myeloma Cancer Study -- PR-USA.Net
- 2011-05-13 - Experts Recommend Intravenous Bisphosphonates For Multiple Myeloma Bone Disease (IMW 2011)
- 2011-05-12 - Robert Orlowski, MD, PhD of MD Anderson Announces the Release of 'The Myeloma Daily' on Twitter Today with 57 Articles from 44 Contributors- Managing Myeloma
- 2011-05-12 - Pat’s Place: Extraordinary People Who Inspire Me Since My Myeloma Diagnosis
- 2011-05-11 - IMW 2011 Multiple Myeloma Update – Day 4 -- The Myeloma Beacon
- 2011-05-10 - IMW 2011 Multiple Myeloma Update – Day Three Part 2 -- The Myeloma Beacon
- 2011-05-09 - IMW 2011 Multiple Myeloma Update – Day Three Part 1 -- The Myeloma Beacon
- 2011-05-07 - Circulating osteopontin: a dual marker of bone destruction and angiogenesis in patients with multiple myeloma. --7th Space
- 2011-05-06 - IMW 2011 Multiple Myeloma Update – Day Two -- The Myeloma Beacon
- 2011-05-06 - Bortezomib Improved Outcomes in Multiple Myeloma Patients After Transplant in Nordic Myeloma Study -- Businesswire Millennium/Takeda
- 2011-05-06 - Secondary Cancers Resurface in Lenalidomide Maintenance Trial Data Along with Significantly Better Outcomes for Patients Treated Long-term with Lenalidomide -- Internal Medicine News
- 2011-05-05 - Multiple Myeloma Research Foundation (MMRF) and Astellas Pharma Global Development Enter into Joint Collaboration to Accelerate Drug Development for Myeloma Patients -- MMRF/Businesswire
- 2011-05-05 - Intergroup Phase III Study (CALGB 100104) Reports Overall Survival Benefit with Lenalidomide As Continuous Therapy for Patients with Multiple Myeloma --Businesswire Celgene
- 2011-05-04 - A Vaccine to Attack Cancer Early- Technology Review/MIT
- 2011-05-04 - NEWS ALERT: IMW 2011 Multiple Myeloma Update – Day One -- The Myeloma Beacon